Maintenance Notice (2:00 - 4:00 AM July 12, 2026 UTC): The website is scheduled for maintenance. The website will be available, but some functions may experience errors. We appreciate your patience and understanding.
Product Document Searching Made Easy by 2D Code! | TCI Life Science News July 2026 | [Product Highlights] Mitochondrial Membrane Potential... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
CAS RN: 88416-50-6 | Product Number: D4160
Disodium Clodronate Tetrahydrate
Purity: >95.0%(T)
- Clodronic Acid Disodium Salt Tetrahydrate
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | D4160 |
Purity / Analysis Method
|
>95.0%(T) |
| Molecular Formula / Molecular Weight | CH__2Cl__2Na__2O__6P__2·4H__2O = 360.91 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image), 5G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 88416-50-6 |
Related CAS RN
|
22560-50-5 |
| PubChem Substance ID | 253660294 |
| Merck Index (14) | 2371 |
| MDL Number | MFCD02940846 |
| Appearance | White to Almost white powder to crystal |
| Purity(Neutralization titration) | min. 95.0 % |
| Water | 18.0 to 22.0 % |
| NMR | confirm to structure |
| H.S.code* | 2931.59-000 |
References
- 1)Bisphosphonates: From bench to bedside
- 2)Computational insights into binding of bisphosphonates to farnesyl pyrophosphate synthase
- 3)Tumour macrophages as potential targets of bisphosphonates
- 4)Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach
- 5)Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
- 6)Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages
- 7)Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.